{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T21:00:11Z","timestamp":1789333211699,"version":"build-2803163510"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:p>This cross-sectional study analyzes data from the National Health Interview Survey to examine the prevalence of cost-related prescription drug rationing by adults with obesity.<\/jats:p>","DOI":"10.1001\/jamanetworkopen.2024.33000","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T16:00:57Z","timestamp":1730822457000},"page":"e2433000","source":"Crossref","is-referenced-by-count":9,"title":["Cost-Related Prescription Drug Rationing by Adults With Obesity"],"prefix":"10.1001","volume":"7","author":[{"given":"Alissa S.","family":"Chen","sequence":"first","affiliation":[{"name":"National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline G.","family":"Borden","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen E.","family":"Canavan","sequence":"additional","affiliation":[{"name":"Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Ross","sequence":"additional","affiliation":[{"name":"National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut"},{"name":"Center for Outcomes Research and Evaluation, Yale New Haven Health System, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol R.","family":"Oladele","sequence":"additional","affiliation":[{"name":"Equity Research and Innovation Center, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia J.","family":"Lipska","sequence":"additional","affiliation":[{"name":"Center for Outcomes Research and Evaluation, Yale New Haven Health System, New Haven, Connecticut"},{"name":"Section of Endocrinology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"zld240147r1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ahj.2021.04.011","article-title":"Financial burden, distress, and toxicity in cardiovascular disease.","volume":"238","author":"Slavin","year":"2021","journal-title":"Am Heart J"},{"issue":"15","key":"zld240147r2","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/jama.2019.15547","article-title":"US public\u2019s perspective on prescription drug costs.","volume":"322","author":"Kirzinger","year":"2019","journal-title":"JAMA"},{"issue":"24","key":"zld240147r3","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes.","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"15","key":"zld240147r5","doi-asserted-by":"publisher","first-page":"S307","DOI":"10.37765\/ajmc.2022.89294","article-title":"Managed care considerations of weight management interventions for obesity.","volume":"28","author":"Amaro","year":"2022","journal-title":"Am J Manag Care"},{"key":"zld240147r4","unstructured":"Smith? T. Drugs used for weight loss could cost Americans much more than people in peer countries. KFF. Accessed January 18, 2024. https:\/\/www.kff.org\/health-costs\/press-release\/drugs-used-for-weight-loss-could-cost-americans-much-more-than-people-in-peer-countries\/"},{"key":"zld240147r6","doi-asserted-by":"crossref","unstructured":"Rodriguez? PJ, Gratzl? S, Cartwright? BMG, Brar? R, Gluckman? TJ, Stucky? NL. First-time prescribing of GLP-1 receptor agonists from 2018-2023: a descriptive analysis.? medRxiv. Preprint posted online August 25, 2023. doi:10.1101\/2023.08.22.23294277","DOI":"10.1101\/2023.08.22.23294277"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2825644\/chen_2024_ld_240147_1729873234.91732.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T16:00:58Z","timestamp":1730822458000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2825644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":6,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.33000","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]}}}